Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

Completed · Phase 4

Conditions studied: Acne Vulgaris

In brief

Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.

Key facts

Study ID

NCT00635609

Run by

Warner Chilcott

People needed

93

Starts

2008-03-01

Expected to finish

2008-09-01

Last updated by the study team

2012-04-20

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be 12 years of age or older.
• Has a diagnosis of facial acne vulgaris with no more than two nodules on the face.

You may not qualify if…

• Is allergic to tetracycline-class antibiotics or to any ingredient in the study medication.
• Has a history of pseudomembranous colitis or antibiotic-associated colitis.
• Has a history of hepatitis or liver damage or renal impairment.

Where it is running

• Warner Chilcott Investigational Site — Vista, California, United States
• Warner Chilcott Investigational Site — Miami, Florida, United States
• Warner Chilcott Investigational Site — Louisville, Kentucky, United States
• Warner Chilcott Investigational Site — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.